MEDICIS PHARMACEUTICAL CORP Contracts & Agreements
106 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (7)
- Human Resources (2)
- Mergers & Acquisitions (3)
- Uncategorized (82)
- SUPPLEMENTAL INDENTURE MEDICIS PHARMACEUTICAL CORPORATION 1.5% Contingent Convertible SeniorNotes Due 2033 SECOND SUPPLEMENTAL INDENTURE DATED AS OF DECEMBER 11, 2012 Deutsche... (Filed With SEC on December 11, 2012)
- SUPPLEMENTAL INDENTURE MEDICIS PHARMACEUTICAL CORPORATION 2.5% Contingent Convertible SeniorNotes Due 2032 FIRST SUPPLEMENTAL INDENTURE DATED AS OF DECEMBER 11, 2012 Deutsche... (Filed With SEC on December 11, 2012)
- SUPPLEMENTAL INDENTURE MEDICIS PHARMACEUTICAL CORPORATION 1.375% Convertible Senior Notes due2017 SECOND SUPPLEMENTAL INDENTURE DATED AS OF DECEMBER 11, 2012 Deutsche BankTrust... (Filed With SEC on December 11, 2012)
- AMENDMENT TO STOCK PURCHASE AGREEMENT (Filed With SEC on November 9, 2012)
- AGREEMENT AND PLAN OF MERGER Among MEDICISPHARMACEUTICAL CORPORATION, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC. and MERLIN MERGER SUB,... (Filed With SEC on September 5, 2012)
- SETTLEMENT AGREEMENT (Filed With SEC on September 5, 2012)
- MEDICIS PHARMACEUTICAL CORPORATION 1.375% CONVERTIBLE SENIOR NOTES DUE 2017 UNDERWRITING AGREEMENT May 10, 2012 (Filed With SEC on May 16, 2012)
- MEDICIS PHARMACEUTICAL CORPORATION INDENTURE Dated as of May 16, 2012 Deutsche BankTrust Company Americas Trustee TABLE OF CONTENTS (Filed With SEC on May 16, 2012)
- MEDICIS PHARMACEUTICALCORPORATION FIRST SUPPLEMENTAL INDENTURE Dated as of May 16, 2012 to INDENTURE Dated as of May 16, 2012 Deutsche BankTrust Company Americas Trustee 1.375%... (Filed With SEC on May 16, 2012)
- JPMorgan Chase Bank, NationalAssociation Organised under the laws of the United States as a National Banking Association Main Office 1111 Polaris Parkway, Columbus, Ohio 43271... (Filed With SEC on May 16, 2012)
- JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association Main Office 1111 Polaris Parkway, Columbus, Ohio 43271... (Filed With SEC on May 16, 2012)
- JPMorgan Chase Bank, NationalAssociation Organised under the laws of the United States as a National Banking Association Main Office 1111 Polaris Parkway, Columbus, Ohio 43271... (Filed With SEC on May 16, 2012)
- JPMorgan Chase Bank, National Association Organised under the laws of the UnitedStates as a National Banking Association Main Office 1111 Polaris Parkway, Columbus, Ohio 43271... (Filed With SEC on May 16, 2012)
- AMENDMENT NO. 1 TO LICENSE AND SETTLEMENT AGREEMENT (Filed With SEC on May 8, 2012)
- 7720 N. Dobson Road, Scottsdale, AZ 85256 ###-###-#### Fax: 602 ###-###-#### (Filed With SEC on May 8, 2012)
- AMENDED AND RESTATED COLLABORATION AGREEMENT by and between UCYCLYD PHARMA, INC. and HYPERION THERAPEUTICS, INC. Dated March 22, 2012 (Filed With SEC on May 8, 2012)
- ASSET PURCHASE AGREEMENT DATED AS OF NOVEMBER 18, 2011 BY AND BETWEEN MEDICIS PHARMACEUTICAL CORPORATION AND GRACEWAY PHARMACEUTICALS, LLC AND THE OTHER PARTIES SIGNATORY HERETO... (Filed With SEC on November 23, 2011)
- LICENSE AND SETTLEMENT AGREEMENT (Filed With SEC on November 9, 2011)
- LICENSE AND SETTLEMENT AGREEMENT (Filed With SEC on November 9, 2011)
- LICENSE AND SETTLEMENT AGREEMENT (Filed With SEC on November 9, 2011)
- STOCK PURCHASE AGREEMENT by and between MEDICIS PHARMACEUTICAL CORPORATION(Seller) and SOLTA MEDICAL, INC. (Buyer) dated as of September 12, 2011 Table of Contents (Filed With SEC on November 9, 2011)
- AMENDMENT NO. 1 TO THE MEDICIS PHARMACEUTICAL CORPORATION SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (Filed With SEC on November 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on May 10, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on March 1, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on March 1, 2011)
- AMENDMENT NO. 6 TO THE MEDICIS 2006 INCENTIVE AWARD PLAN (Filed With SEC on February 15, 2011)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on November 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on November 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on November 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2010)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 9, 2010)
- Item 1. Business (Filed With SEC on March 1, 2010)
- Item 1. Business (Filed With SEC on March 1, 2010)
- Item 1. Business (Filed With SEC on March 1, 2010)
- Item 1. Business (Filed With SEC on March 1, 2010)
- Item 1. Business (Filed With SEC on March 1, 2010)
- Item 1. Business (Filed With SEC on March 1, 2010)
- Current assets (Filed With SEC on November 9, 2009)
- Current assets (Filed With SEC on August 10, 2009)
- Current assets (Filed With SEC on May 11, 2009)
- Current assets (Filed With SEC on May 11, 2009)
- Current assets (Filed With SEC on May 11, 2009)
- Current assets (Filed With SEC on May 11, 2009)
- Current assets (Filed With SEC on May 11, 2009)
- U.S. Market Impact (Filed With SEC on March 2, 2009)
- U.S. Market Impact (Filed With SEC on March 2, 2009)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 30, 2008)
- Current assets (Filed With SEC on August 11, 2008)
- U.S. Market Impact (Filed With SEC on February 29, 2008)
- U.S. Market Impact (Filed With SEC on February 29, 2008)
- Current assets (Filed With SEC on November 9, 2006)
- Current assets (Filed With SEC on August 9, 2006)
- Mark A. Prygocki, Sr (Filed With SEC on July 31, 2006)
- Mark A. Prygocki, Sr (Filed With SEC on July 31, 2006)
- Mark A. Prygocki, Sr (Filed With SEC on July 31, 2006)
- Mark A. Prygocki, Sr (Filed With SEC on July 31, 2006)
- Current assets (Filed With SEC on May 10, 2006)
- Current assets (Filed With SEC on May 10, 2006)
- Current assets (Filed With SEC on May 10, 2006)
- Aesthetica, Ltd. Medicis Pharmaceutical Corp. Medicis Aesthetics Holdings, Inc. 8125 North Hayden Road Scottsdale, Arizona 85258 Dated as of March 13, 2006 (Filed With SEC on March 16, 2006)
- Third Amendment, dated December 30, 2005, between the Company and Jonah Shacknai (Filed With SEC on January 3, 2006)
- The proposal to approve the issuance of shares of Medicis Class A common stock pursuant to the Merger Agreement (Filed With SEC on December 13, 2005)
- Current assets (Filed With SEC on November 9, 2005)
- Current assets (Filed With SEC on November 9, 2005)
- Current assets (Filed With SEC on November 9, 2005)
- Current assets (Filed With SEC on November 9, 2005)
- Current assets (Filed With SEC on November 9, 2005)
- TERMINATION AGREEMENT (Filed With SEC on October 20, 2005)
- U.S. Market Impact (Filed With SEC on September 13, 2005)
- U.S. Market Impact (Filed With SEC on September 13, 2005)
- AMENDED AND RESTATED RIGHTS AGREEMENT by and between MEDICIS PHARMACEUTICAL CORPORATION and WELLS FARGO BANK, N.A., as Rights Agent Dated as of August 17, 2005 (Filed With SEC on August 18, 2005)
- Current assets (Filed With SEC on May 10, 2005)
- Agreement and Plan of Merger, dated as of March 20, 2005, by and among Medicis Pharmaceutical Corporation, a Delaware corporation, Masterpiece Acquisition Corp., a Delaware... (Filed With SEC on March 21, 2005)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- U.S. Market Impact (Filed With SEC on September 10, 2004)
- Financial Statements of Business Acquired (Filed With SEC on March 10, 2003)
- Financial Statements of Business Acquired (Filed With SEC on March 10, 2003)
- Financial Statements of Business Acquired (Filed With SEC on March 10, 2003)
- Financial Statements of Business Acquired (Filed With SEC on March 10, 2003)
- U.S. Market Impact (Filed With SEC on September 30, 2002)
- to fund the purchase of up to $142.5 million of our Class A common stock, in connection with short sales of our common stock by purchasers of the Notes (Filed With SEC on June 6, 2002)
- to fund the purchase of up to $142.5 million of our Class A common stock, in connection with short sales of our common stock by purchasers of the Notes (Filed With SEC on June 6, 2002)
- PART I. FINANCIAL INFORMATION (Filed With SEC on May 15, 2001)
- PART I. FINANCIAL INFORMATION (Filed With SEC on May 15, 2001)
